Reed Smith is pleased to present a virtual CLE week designed for in-house counsel at pharmaceutical, medical device, biotech, and digital health companies.

Sessions will cover hot topics and key developments in artificial intelligence, drug pricing, ethics, fraud and abuse, product liability, toxic tort, transactions, and women’s health.

Oradores:: Jaclyn M. Setili Wood Christian W. Castile Charlotte Flynn

Tipo de evento: Seminario web, Educación legal continua/desarrollo profesional continuo

Fecha/hora de inicio:
6 November 2025, 12:00 PM ET
Fecha/hora de finalización:
6 November 2025, 1:00 PM ET

As courts grapple with the rise of AI-generated filings and discovery tools, savvy litigants must stay ahead of evolving standards, ethical rules surrounding use of AI, and potential misuse in the hands of adversaries. This program will examine real-world examples of improper AI usage (and judicial responses) – and their ethical implications – to identify key takeaways for modern litigants. Join us for an engaging discussion around how to handle “hallucinated” case law, challenge AI-generated evidence, and draft protective orders that safeguard privacy and confidentiality.

This is Part 8 of a eleven-part series. Part 1, The New EU Product Liability Directive: A Game-Changer for Biopharma, Medtech, and Digital Health Companies, is taking place on November 3, 2025, Part 2, Life Sciences Early-Stage Dealmaking: Trends and Diligence Strategy, is taking place on November 3, 2025, Part 3, Navigating the Evolving Frontier of Women’s Health and Fertility Treatments, is taking place on November 4, 2025, Part 4, From Pharma to Produce: California’s Evolving Tort Terrain, is taking place on November 4, Part 5, AI and Life Sciences: A Collision Course, is taking place on November 4, Part 6, Recent Developments in Vaccine Product Liability Litigation, is taking place on November 5, Part 7, A World Without Government Pricing Programs, is taking place on November 5, Part 9, Hot Topics in Fraud and Abuse for Medical Device Manufacturers, is taking place on November 6, Part 10, Toxic Tort Litigation in the Life Sciences and Consumer Health Industry: Key Cases and Emerging Trends, is taking place on November 7, Part 11, Something New Under the Sun? Novel Preemption Topics, is taking place on November 7.

CLE Information: This webinar is presumptively approved for 1.0 CLE ethics credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Applications for CLE credit will be filed in Colorado, Delaware, Florida, Georgia, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance, but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.